Evaluation of Convalescent Plasma in the Management of Critically Ill COVID-19 Patients (with No Detectable Neutralizing Antibodies Nab) in Kashmir, India

Evaluation of Convalescent Plasma in the Management of Critically Ill COVID-19 Patients (with No Detectable Neutralizing Antibodies Nab) in Kashmir, India

Background: For centuries, convalescent plasma (CP) has been recommended to treat a diverse set of viral diseases. Therefore, the present study was undertaken to evaluate the effectiveness of CP in critically ill COVID-19 patients. Methods and Materials: From 23 March 2021 to 29 December 2021, an op...

Full description

Bibliographic Details
Main Authors:	Ahmed M. E. Elkhalifa, Showkat Ul Nabi, Naveed Nazir Shah, Khurshid Ahmad Dar, Syed Quibtiya, Showkeen Muzamil Bashir, Sofi Imtiyaz Ali, Syed Taifa, Iqra Hussain
Format:	Article
Language:	English
Published:	MDPI AG 2023-01-01
Series:	Healthcare
Subjects:	convalescent plasma COVID-19 best standard treatment historical control all-cause mortality oxygen saturation
Online Access:	https://www.mdpi.com/2227-9032/11/3/317

Similar Items

Comparing SARS-CoV-2 neutralizing antibody levels in convalescent unvaccinated, convalescent vaccinated, and naive vaccinated subjects
by: Latha Dulipsingh, et al.
Published: (2023-06-01)

Korean version of the convalescence and recovery evaluation: translation and linguistic validation
by: Hyeong Dong Yuk, et al.
Published: (2020-12-01)

The effect of convalescent plasma on the treatment of COVID-19 patients in Ardabil, Iran
by: Effat Iranijam, et al.
Published: (2022-01-01)

Convalescent plasma therapy in COVID-19
by: Ayse Uysal, et al.
Published: (2022-06-01)

Use of convalescent plasma to treat COVID-19: case studies
by: Stéphani Caroline Beneti, et al.
Published: (2023-07-01)

Biomarkers of sequela in adult patients convalescing from COVID-19
by: Vianed Marsán-Suárez, et al.
Published: (2022-01-01)

Convalescent Plasma Transfusion for the Treatment of COVID-19—Experience from Poland: A Multicenter Study
by: Anna Moniuszko-Malinowska, et al.
Published: (2020-12-01)

Development and validation of the Convalescence Symptom Assessment Scale for EsophageCtomy patients
by: Hui Ge, et al.
Published: (2024-02-01)

Rapid Clinical and Radiological Improvement in a Patient with Severe COVID-19 Infection Treated with Convalescent Plasma
by: Stephen Malnick, et al.
Published: (2021-05-01)

Convalescent Plasma for Hospitalized COVID-19 Patients: A Single-Center Experience
by: Massimo Franchini, et al.
Published: (2022-03-01)

Early Administration of Convalescent Plasma Improves Survival in Patients with Hematological Malignancies and COVID-19
by: Monika Maria Biernat, et al.
Published: (2021-03-01)

Potential predictors of outcomes among hospitalized COVID-19 patients treated with convalescent plasma: a single-center study
by: Sridhar Chilimuri, et al.
Published: (2021-07-01)

Acute Malaria in Malawian Children and Adults is Characterized by Thrombocytopenia That Normalizes in Convalescence
by: Mandala W, et al.
Published: (2022-09-01)

Convalescent Plasma Reduces Endogenous Antibody Response in COVID-19: A Retrospective Cross-Sectional Study
by: Ahmet Omma, et al.
Published: (2021-12-01)

Prediction of early falls using adherence and balance assessments in a convalescent rehabilitation ward
by: Toshio Teranishi, et al.
Published: (2024-02-01)

Immunomodulation Effect of Convalescent Plasma Therapy in Severe – Critical COVID-19 Patients
by: Fitriah M, et al.
Published: (2023-04-01)

Convalescent Plasma in Older Adults with COVID-19: A Systematic Review and Meta-Analysis
by: I Gusti Putu Suka Aryana, et al.
Published: (2022-09-01)

Reducing the use of psychotropics in a convalescent rehabilitation ward
by: Takuya Uematsu, et al.
Published: (2024-03-01)

Safety and Efficacy of Convalescent Plasma in COVID-19: An Overview of Systematic Reviews
by: Massimo Franchini, et al.
Published: (2021-09-01)

Home and Out-of-Hospital Therapy with COVID-19 Convalescent Plasma in Europe
by: Daniele Focosi, et al.
Published: (2022-10-01)

To which extent a convalescent plasma therapy could be a benefit for COVID-19 patients?
by: Abdelmonem Ali, et al.
Published: (2020-11-01)

Convalescent Plasma Transfusion for the Treatment of COVID-19 in Adults: A Global Perspective
by: Saly Kanj, et al.
Published: (2021-05-01)

COVID-19 Serology Data Provide Guidance for Future Deployments of Convalescent Plasma
by: David Sullivan, et al.
Published: (2023-06-01)

Convalescent (Immune) Plasma Therapy with all Aspects: Yesterday, Today and COVID-19
by: Öner Özdemir, et al.
Published: (2020-06-01)

Effectiveness of Convalescent Plasma Therapy in Treating COVID-19: an Evidence-based Case Report
by: Mira Yulianti, et al.
Published: (2022-01-01)

Rapid and Successful Implementation of a COVID-19 Convalescent Plasma Programme—The South African Experience
by: Tanya Nadia Glatt, et al.
Published: (2021-10-01)

Convalescent Plasma for Pregnant Women with COVID-19: A Systematic Literature Review
by: Massimo Franchini, et al.
Published: (2021-06-01)

СASES OF HUMAN CONVALESCENCE FROM RABIES AND LIFETIME DIAGNOSTICS OF LYSSAVIRUS ENCEPHALITIS
by: A. E. Metlin, et al.
Published: (2019-02-01)

The Three Pillars of COVID-19 Convalescent Plasma Therapy
by: Massimo Franchini, et al.
Published: (2021-04-01)

Residual and Late Onset Symptoms Appeared in a Patient with Severe Fever with Thrombocytopenia in a Convalescence Stage
by: Kohei Kanda, et al.
Published: (2021-04-01)

Convalescent plasma therapy in the management of COVID-19 patients and its effect on morbidity and mortality
by: Madhav Prabhu, et al.
Published: (2023-01-01)

Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients—An Open-Label Phase II Clinical Trial
by: Rada M. Grubovic Rastvorceva, et al.
Published: (2022-10-01)

Antibody False Positivity Among COVID-19 Convalescent Plasma Donors: A Comparative Study from the Turkish Red Crescent Blood Center
by: Levent Hayat, et al.
Published: (2021-11-01)

Characteristics and Motivational Factors of Whole Blood and Convalescent Plasma Donors during the SARS-CoV-2 Pandemic in Israel
by: Eilat Shinar, et al.
Published: (2024-03-01)

Use of Early Donated COVID-19 Convalescent Plasma Is Optimal to Preserve the Integrity of Lymphatic Endothelial Cells
by: Nada Amri, et al.
Published: (2022-03-01)

Immunoglobulins or convalescent plasma to tackle COVID-19: buying time to save lives – current situation and perspectives
by: Adriana Tamburello, et al.
Published: (2020-04-01)

The Efficacy of Convalescent Plasma Use in Critically Ill COVID-19 Patients
by: Livius Tirnea, et al.
Published: (2021-03-01)

SEIR Mathematical Model of Convalescent Plasma Transfusion to Reduce COVID-19 Disease Transmission
by: Hennie Husniah, et al.
Published: (2021-11-01)

Convalescent plasma therapy for coronavirus infection: experience from MERS and application in COVID-19
by: Jaffar A. Al-Tawfiq, et al.
Published: (2020-12-01)

Convalescent Plasma for COVID-19: A Single Center Prospective Experience with Serial Antibody Measurements and Review of the Literature
by: Sonia N. Whang, et al.
Published: (2022-08-01)